4//SEC Filing
ARCA biopharma, Inc. 4
Accession 0001209191-15-014720
$ORKACIK 0000907654operating
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 6:14 PM ET
Size
8.4 KB
Accession
0001209191-15-014720
Insider Transaction Report
Form 4
Ozeroff Christopher David
EVP & General Counsel
Transactions
- Award
Common Stock
2015-02-12+24,050→ 150,787 total - Award
Stock Option (right to buy)
2015-02-12+12,950→ 12,950 totalExercise: $0.67Exp: 2025-02-11→ Common Stock (12,950 underlying)
Footnotes (3)
- [F1]Represents shares issued as restricted stock units (an "RSU") under the Issuer's 2013 Equity Incentive Plan (the "Plan"). The RSUs vest in three equal annual installments beginning April 2, 2016, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time.
- [F2]Includes 84,200 previously reported shares issued as restricted stock units under the Plan and 42,537 previously reported shares of common stock held directly.
- [F3]Grant to the Reporting Person of a stock option under the Plan, vesting in 36 equal monthly installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time. In the event of a change in control of the Issuer, 50% of the unvested options shall become fully and immediately vested upon the closing date of such change in control, provided, however, that on the earlier of (i) the one-year anniversary of the closing date or (ii) involuntary termination, any options that remain unvested on such earlier date shall become fully and immediately vested.
Documents
Issuer
ARCA biopharma, Inc.
CIK 0000907654
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000907654
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 6:14 PM ET
- Size
- 8.4 KB